Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. The selection includes GLP-1 care and NAD+ creator messages. The peptide waitlist is a separately sourced page reference. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A dedicated offer page combines pricing presentation, treatment plans, customer stories, care inclusions and the online-care entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The creative is clean and confident: one price, one badge, one product, with the Fridays logo low and readable. The $99/mo banner names the plan right under it (12-month compounded GLP-1), which is more honest than leaving it to the footnote. The copy is short and states the mechanism in a line, prescribed online and shipped to your door, so a viewer knows what kind of service this is. Fridays ran several versions of this from October 11, 2026.
The photo puts a branded Zepbound pen right next to the $99 price, while the price itself is for compounded semaglutide; a viewer could reasonably think the pen is what $99 buys. The landing page then lists tirzepatide at a higher starting price, so that expectation gets corrected after the click, not before. If you sell more than one option, show only the product the headline price covers, and the copy's weight-loss claim should stay attributed with its footnote, as Fridays does with the asterisk.
The banner puts price and plan length together so the offer is clear at a glance.
The product shot and badge give the price something physical and credible to attach to.
It pairs an outcome claim with a one-line explanation of how the service works.
The headline repeats the lock so the price is the last thing read before the click.
$99 a month, locked in forever, on a 12-month compounded GLP-1 plan.
The ad goes to the price-lock offer page, a focused landing page rather than a general site. The coupon hero says as low as $99 a month with forever pricing, which picks up the banner directly, and the next block spells out that semaglutide is $99 while tirzepatide starts higher. Plans, customer stories, the care team and the start process follow, then safety information, so the visitor gets the detail the static ad doesn't have room for.
A dedicated Fridays offer page for GLP-1 care that opens on a coupon-style card promising as low as $99 a month with forever pricing, then moves through drug prices, plans, customer stories, the care team and safety information. 12 Fridays ads in the library send people here, mostly creator stories and price-lock statics.
A dashed coupon card announces GLP-1 care as low as $99 a month with forever pricing, a countdown and a Lock in my price button, answering what's the deal.
A Now as Low as $99/mo GLP-1 Weight Loss headline lists semaglutide and tirzepatide prices, included clinical care and a two-minute qualification, answering what exactly do I get for that price.
A before-and-after photo pair with a vial sits beside a rating line that cites reviews and a success-rate figure, answering does anyone like this.
A row of media logos (Bloomberg, Forbes, Healthline, WebMD, Fortune, Fast Company) answers is this a company people have heard of.
Plans and a comparison lay out the options side by side, answering which one should I pick.
Stories from customers answer what was it like for someone like me.
This section shows the care that comes with the plan and the clinicians behind it, answering who's actually looking after me.
The steps to get started answer what happens after I click.
Questions and safety details close the page, answering the remaining what-ifs and the required disclosures.
Read the full breakdown of this page
One of 21 Fridays ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.